TIMI 31

OBJECTIVE: To evaluate the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST-elevation myocardial infarction.

View/Download
_______________________________________________________________________________

1. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial. Gibson CM, Zorkun C, Molhoek P, et al. J Thromb Thrombolysis 2006;22:13-21.
   | Abstract | Request Reprints |